Ambrosia Medical have recently proposed to transfuse blood from young donors to older people with the hope of slowing down the process of organ aging. This start-up even aims to open up it’s first clinic in New York before the end of the year.
Transfusing blood from young donors to older people aims to slow down the effects of aging. On paper the procedure is ambitious but many people want to try it. The start-up’s first clinical trial set up in 2017 treated 150 patients aged between 35 and 92 years. The trial patients received fresh blood transfusions (1.5 liters of plasma) from young donors aged 16 to 25 years. However the results of these experiments have yet to be published.
However that doesn’t stop Jesse Karmazin, Stanford University graduate and start-up founder from proposing the opening off the first New York clinic before the end of the year. Blood transfusions have already been approved by Food and Drug Administration (FDA). In an interview with Business Insider David Cavalier, Ambrosia’s chief operating officer explained that, “The trial was an investigational study. We saw some interesting things and we do plan to publish that data.” He continued, “We want to begin to open clinics where the treatment will be made available“.
The two friends are now looking for sites for their first clinic and potential investors in New York. And they seem to have an attractive proposal as the start-up has already received a hundred requests for further information. They have already set up a waiting list so you can register yourself for a treatment. Although no price has been formally released as of yet, the bill could be near to $ 8,000.
If Jesse Karmazin and David Cavalier remain optimistic about their project, others are less so. Tony Wyss-Coray a neuroscientist from Stanford University, said “There’s just no clinical evidence [that the treatment will be beneficial], and you’re basically abusing people’s trust and the public excitement around this.” Without published data, the beneficial “powers” of young blood remain unknown. However, all the same, participants in the experiment could have noticed better levels of concentration, improved sleep, better memory and muscular health.